
    
      The study consisted of three study periods as follows:

        -  Screening period: up to 6 weeks

        -  Treatment period: minimum 52 weeks (primary treatment period) up to a maximum of 104
           weeks (extended treatment period)

        -  Post-Treatment Follow-Up period: 4 weeks
    
  